[go: up one dir, main page]

FI965030L - N-terminally extended proteins expressed in yeast - Google Patents

N-terminally extended proteins expressed in yeast Download PDF

Info

Publication number
FI965030L
FI965030L FI965030A FI965030A FI965030L FI 965030 L FI965030 L FI 965030L FI 965030 A FI965030 A FI 965030A FI 965030 A FI965030 A FI 965030A FI 965030 L FI965030 L FI 965030L
Authority
FI
Finland
Prior art keywords
yeast
proteins expressed
terminally extended
extended proteins
terminally
Prior art date
Application number
FI965030A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI965030A7 (en
FI965030A0 (en
Inventor
Knud Vad
Jakob Brandt
Thomas Boerglum Kjeldsen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of FI965030A0 publication Critical patent/FI965030A0/en
Publication of FI965030A7 publication Critical patent/FI965030A7/en
Publication of FI965030L publication Critical patent/FI965030L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
FI965030A 1994-06-17 1995-06-16 N-terminally extended proteins expressed in yeast FI965030L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK71294 1994-06-17
PCT/DK1995/000250 WO1995035384A1 (en) 1994-06-17 1995-06-16 N-terminally extended proteins expressed in yeast

Publications (3)

Publication Number Publication Date
FI965030A0 FI965030A0 (en) 1996-12-16
FI965030A7 FI965030A7 (en) 1997-02-14
FI965030L true FI965030L (en) 1997-02-14

Family

ID=8096676

Family Applications (1)

Application Number Title Priority Date Filing Date
FI965030A FI965030L (en) 1994-06-17 1995-06-16 N-terminally extended proteins expressed in yeast

Country Status (16)

Country Link
EP (1) EP0765395A1 (en)
JP (1) JP3730255B2 (en)
CN (1) CN1131312C (en)
AU (1) AU2733595A (en)
BR (1) BR9508053A (en)
CA (1) CA2192943A1 (en)
CZ (1) CZ363796A3 (en)
FI (1) FI965030L (en)
HU (1) HUT75840A (en)
IL (1) IL114160A (en)
MX (1) MX9606536A (en)
NO (1) NO965411L (en)
PL (1) PL317761A1 (en)
SG (1) SG47883A1 (en)
WO (1) WO1995035384A1 (en)
ZA (1) ZA954983B (en)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500645B1 (en) 1994-06-17 2002-12-31 Novo Nordisk A/S N-terminally extended proteins expressed in yeast
ZA9610456B (en) * 1995-12-20 1997-06-20 Novo Nordisk As N-terminally extended proteins expressed in yeast
WO1998025963A1 (en) * 1996-12-13 1998-06-18 Chiron Corporation Analysis and separation of platelet-derived growth factor proteins
EP0946735B1 (en) * 1996-12-20 2006-02-08 Novo Nordisk A/S N-terminally extended proteins expressed in yeast
WO1999037793A1 (en) 1998-01-23 1999-07-29 Novo Nordisk A/S Process for making desired polypeptides in yeast
HUP0301640A2 (en) 1999-12-29 2003-08-28 Novo Nordisk A/S. Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
US20030082671A1 (en) 2001-07-24 2003-05-01 Thomas Hoeg-Jensen Method for making acylated polypeptides
US7595172B2 (en) 2001-07-24 2009-09-29 Novo Nordisk A/S Method for making acylated polypeptides
WO2003010185A2 (en) * 2001-07-24 2003-02-06 Novo Nordisk A/S Method for making acylated polypeptides
WO2004085472A1 (en) * 2003-03-27 2004-10-07 Novo Nordisk A/S Method for making human insulin precursors and human insulin
ATE517119T1 (en) 2003-12-03 2011-08-15 Novo Nordisk As SINGLE CHAIN INSULIN
CN101243190B (en) 2005-08-16 2015-05-13 诺沃-诺迪斯克有限公司 Method for preparing mature insulin polypeptide
WO2008015099A2 (en) * 2006-07-31 2008-02-07 Novo Nordisk A/S Pegylated, extended insulins
JP5864834B2 (en) 2006-09-22 2016-02-17 ノボ・ノルデイスク・エー／エス Protease resistant insulin analogue
ES2464282T3 (en) 2006-09-27 2014-06-02 Novo Nordisk A/S Method for preparing mature insulin polypeptides
WO2008062010A2 (en) 2006-11-22 2008-05-29 Novo Nordisk A/S Method for making activated carboxypeptidases
WO2009010428A1 (en) 2007-07-16 2009-01-22 Novo Nordisk A/S Protease stabilized, pegylated insulin analogues
JP5710253B2 (en) 2007-08-13 2015-04-30 ノボ・ノルデイスク・エー／エス Fast-acting insulin analogue
JP5721432B2 (en) 2007-08-15 2015-05-20 ノボ・ノルデイスク・エー／エス Insulin having an acyl moiety containing an amino acid-containing alkylene glycol repeating unit
EP2178912B1 (en) 2007-08-15 2015-07-08 Novo Nordisk A/S Insulin analogues with an acyl and aklylene glycol moiety
JP5749155B2 (en) 2008-03-18 2015-07-15 ノボ・ノルデイスク・エー／エス Protease stabilized acylated insulin analogue
ES2563553T3 (en) 2008-04-01 2016-03-15 Novo Nordisk A/S Insulin-albumin conjugates
KR101775000B1 (en) 2009-06-26 2017-09-04 노보 노르디스크 에이/에스 Preparation comprising insulin, nicotinamide and an amino acid
CN102639559B (en) 2009-11-25 2015-04-29 诺沃—诺迪斯克有限公司 Methods for preparing polypeptides
CN104693302A (en) 2010-06-23 2015-06-10 诺沃—诺迪斯克有限公司 Insulin derivatives containing additional disulfide bonds
EP2585483A1 (en) 2010-06-23 2013-05-01 Novo Nordisk A/S Human insulin containing additional disulfide bonds
EP2585484A1 (en) 2010-06-23 2013-05-01 Novo Nordisk A/S Insulin analogues containing additional disulfide bonds
WO2012080320A1 (en) 2010-12-14 2012-06-21 Novo Nordisk A/S Fast-acting insulin in combination with long-acting insulin
CN103328006A (en) 2010-12-14 2013-09-25 诺沃—诺迪斯克有限公司 Preparation comprising insulin, nicotinamide and an amino acid
WO2012171994A1 (en) 2011-06-15 2012-12-20 Novo Nordisk A/S Multi substituted insulins
WO2013186138A1 (en) 2012-06-14 2013-12-19 Novo Nordisk A/S Preparation comprising insulin, nicotinamide and arginine
EP2925345B1 (en) 2012-12-03 2018-09-05 Merck Sharp & Dohme Corp. Method for making o-glycosylated carboxy terminal portion (ctp) peptide-based insulin and insulin analogues
CN105308067B (en) 2013-06-07 2020-07-24 诺和诺德股份有限公司 Method for preparing mature insulin polypeptide
ES2700547T3 (en) 2014-02-28 2019-02-18 Novo Nordisk As Variants of alpha mating factor pro-peptide
CN107743494B (en) 2015-06-02 2022-04-29 诺和诺德股份有限公司 Insulin with polar recombinant elongation
JP2018531900A (en) 2015-08-25 2018-11-01 ノヴォ ノルディスク アー／エス Novel insulin derivatives and their medical use
CN108368163A (en) 2015-08-25 2018-08-03 诺和诺德股份有限公司 Novel insulin derivates and its medical usage
JP2018531901A (en) 2015-08-25 2018-11-01 ノヴォ ノルディスク アー／エス Novel insulin derivatives and their medical use
TW201741333A (en) * 2016-05-24 2017-12-01 諾佛 儂迪克股份有限公司 MIC-1 compound and its use
MX2020001434A (en) 2017-08-17 2020-03-20 Novo Nordisk As Novel acylated insulin analogues and uses thereof.
CN112105635A (en) * 2018-06-18 2020-12-18 联合化学实验室有限公司 Leader sequences for higher expression of recombinant proteins
CN110305223B (en) * 2019-06-26 2022-05-13 重庆派金生物科技有限公司 Method for preparing target polypeptide by recombinant tandem fusion protein
KR102427426B1 (en) 2019-12-11 2022-08-01 노보 노르디스크 에이/에스 Novel insulin analogues and uses thereof
WO2023144240A1 (en) 2022-01-26 2023-08-03 Novo Nordisk Research Centre Oxford Limited Glucose sensitive insulin derivatives and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2593518B1 (en) * 1985-05-02 1989-09-08 Transgene Sa VECTORS FOR THE EXPRESSION AND SECRETION OF HIRUDIN BY TRANSFORMED YEASTS
US5010182A (en) * 1987-07-28 1991-04-23 Chiron Corporation DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides
CA1340772C (en) * 1987-12-30 1999-09-28 Patricia Tekamp-Olson Expression and secretion of heterologous protiens in yeast employing truncated alpha-factor leader sequences
DK105489D0 (en) * 1989-03-03 1989-03-03 Novo Nordisk As POLYPEPTIDE
DK300090D0 (en) * 1990-12-19 1990-12-19 Novo Nordisk As PROCEDURE FOR PREPARING LEADER SEQUENCES
WO1992013951A1 (en) * 1991-02-04 1992-08-20 The Salk Institute Biotechnology/Industrial Associates, Inc. Production of human serum albumin in methylotrophic yeast cells

Also Published As

Publication number Publication date
JP3730255B2 (en) 2005-12-21
NO965411L (en) 1997-02-14
HU9603476D0 (en) 1997-02-28
NO965411D0 (en) 1996-12-16
PL317761A1 (en) 1997-04-28
AU2733595A (en) 1996-01-15
FI965030A7 (en) 1997-02-14
FI965030A0 (en) 1996-12-16
CA2192943A1 (en) 1995-12-28
CN1131312C (en) 2003-12-17
CN1152942A (en) 1997-06-25
ZA954983B (en) 1996-02-14
MX9606536A (en) 1997-03-29
IL114160A0 (en) 1995-10-31
IL114160A (en) 2006-12-31
WO1995035384A1 (en) 1995-12-28
JPH10501695A (en) 1998-02-17
HUT75840A (en) 1997-05-28
EP0765395A1 (en) 1997-04-02
SG47883A1 (en) 1998-04-17
CZ363796A3 (en) 1997-05-14
BR9508053A (en) 1997-08-12

Similar Documents

Publication Publication Date Title
FI965030L (en) N-terminally extended proteins expressed in yeast
NO20002990L (en) New surface protein
DK1056883T3 (en) Yeast cell surface protein display and uses thereof
IS5375A (en) KAY-Innovative Immune Protein
DE69635900D1 (en) POWERED COUNTERPIECES
DE69839603D1 (en) ORNAMENTAL PROTEINS
FI970979A7 (en) Modified human C3 proteins
FI972030A7 (en) Purified papillomavirus proteins
FI972763A7 (en) Mutant proteins
NO974924D0 (en) Modified polypeptides with increased immunogenicity
BR9704104A (en) Baker's yeast
TR199701666A3 (en) Proteins
GB9423372D0 (en) Proteins and their uses
KR960010685A (en) Peptides and their uses
EP0804556A4 (en) PROTEIN MODIFYING ENZYME
KR970026844U (en) Portable cutlery
SE9701041D0 (en) Novel proteins and their use
KR970048309U (en) Interface Units in Set Top Units
DE69434900D1 (en) HUMAN CHEMOKIN POLYPEPTIDE
FI1691U1 (en) Hopsaettningsmaskin Foer in lastpalls
SE9602287D0 (en) Novel protein and methods for its use
KR950022452U (en) Cheonggukjang Fermenter
KR970052565U (en) Wheat Glasses
ITCR950001V0 (en) DOUBLE MOVING FURNITURE
BR7400551U (en) Inverted nail